Canadians suffering from certain mental illnesses may qualify for medical assistance in dying (MAiD) from March 2024. However, federal legislation must be adjusted to allow access to psychedelic-assisted therapies, such as psilocybin, which have shown promise especially for treating treatment-resistant depression. Critics argue it’s paradoxical to permit MAiD without first exploring all potentially life-saving treatments. A recently introduced Special Access Program provides some access to psychedelic therapies with Health Canada approval.
Open source leaders are pushing for permanent government financing to maintain open source projects. They argue that as government oversight is vital to the national